X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (494) 494
Publication (57) 57
Book Chapter (12) 12
Newspaper Article (7) 7
Book / eBook (4) 4
Conference Proceeding (4) 4
Patent (3) 3
Web Resource (2) 2
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (132) 132
humans (102) 102
oncology (79) 79
male (63) 63
female (62) 62
cancer (61) 61
radiotherapy (59) 59
middle aged (49) 49
aged (48) 48
article (47) 47
adult (41) 41
analysis (40) 40
aged, 80 and over (31) 31
chemotherapy (29) 29
retrospective studies (28) 28
tumors (28) 28
care and treatment (26) 26
research (26) 26
head and neck cancer (25) 25
radiation (25) 25
surgery (25) 25
treatment outcome (25) 25
mutation (24) 24
radiation therapy (24) 24
squamous-cell carcinoma (24) 24
survival (24) 24
head (23) 23
radiology, nuclear medicine & medical imaging (23) 23
hematology, oncology and palliative medicine (22) 22
patients (21) 21
radiation-therapy (21) 21
health aspects (19) 19
peristaltic flow (19) 19
radiotherapy dosage (18) 18
agriculture, multidisciplinary (17) 17
growth (17) 17
immunotherapy (17) 17
zoology (17) 17
imrt (16) 16
management (16) 16
neck-cancer (16) 16
therapy (16) 16
young adult (16) 16
medical research (15) 15
medicine & public health (15) 15
pakistan (15) 15
physics (15) 15
squamous cell carcinoma (15) 15
usage (15) 15
carcinoma (14) 14
materials science, multidisciplinary (14) 14
medicine, general & internal (14) 14
rectangular duct (14) 14
chemistry (13) 13
human-papillomavirus (13) 13
intensity-modulated radiotherapy (13) 13
neoplasm staging (13) 13
mathematical models (12) 12
methods (12) 12
multidisciplinary sciences (12) 12
oropharyngeal cancer (12) 12
patient outcomes (12) 12
studies (12) 12
toxicity (12) 12
transport (12) 12
carcinoma, squamous cell - radiotherapy (11) 11
carcinoma, squamous cell - therapy (11) 11
chemoradiotherapy (11) 11
deoxyribonucleic acid--dna (11) 11
gene expression (11) 11
genetic aspects (11) 11
genomes (11) 11
imaging / radiology (11) 11
nanoparticles (11) 11
physiological aspects (11) 11
prognosis (11) 11
radiotherapy, intensity-modulated - adverse effects (11) 11
radiotherapy, intensity-modulated - methods (11) 11
risk factors (11) 11
yield (11) 11
animals (10) 10
cohort studies (10) 10
dentistry, oral surgery & medicine (10) 10
disease-free survival (10) 10
fluid dynamics (10) 10
fluid flow (10) 10
head and neck neoplasms - therapy (10) 10
medicine (10) 10
medicine, experimental (10) 10
metastasis (10) 10
nanoscience & nanotechnology (10) 10
pd-1 blockade (10) 10
proteins (10) 10
radiology (10) 10
adolescent (9) 9
bacteria (9) 9
biochemistry & molecular biology (9) 9
biomarkers (9) 9
cancer therapies (9) 9
chemistry, multidisciplinary (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE MEDICINE, ISSN 1078-8956, 05/2019, Volume 25, Issue 5, pp. 767 - 767
Anti-tumor immunity is driven by self versus non-self discrimination. Many immunotherapeutic approaches to cancer have taken advantage of tumor neoantigens... 
MEDICINE, RESEARCH & EXPERIMENTAL | PROTEIN | TUMOR-ANTIGENS | LANDSCAPE | BIOCHEMISTRY & MOLECULAR BIOLOGY | BCR-ABL | INDUCTION | CANCER | SOMATIC MUTATIONS | CELL BIOLOGY | PEPTIDES | IMMUNOTHERAPY | BLOCKADE | Recombinant Fusion Proteins - immunology | Oncogene Proteins - genetics | Immunotherapy - methods | Humans | Proto-Oncogene Proteins c-myb - genetics | Programmed Cell Death 1 Receptor - antagonists & inhibitors | NFI Transcription Factors - genetics | Squamous Cell Carcinoma of Head and Neck - immunology | Neoplasms - therapy | Neoplasms - genetics | Nuclear Proteins - genetics | Oncogene Proteins - immunology | T-Lymphocytes, Cytotoxic - immunology | Antigens, Neoplasm - genetics | Head and Neck Neoplasms - therapy | Poly-ADP-Ribose Binding Proteins - genetics | Gene Fusion | Proto-Oncogene Proteins c-myb - immunology | Nuclear Proteins - immunology | Chromosomal Proteins, Non-Histone - genetics | Whole Genome Sequencing | Chromosomal Proteins, Non-Histone - immunology | Head and Neck Neoplasms - immunology | Squamous Cell Carcinoma of Head and Neck - genetics | Neoplasms - immunology | Recombinant Fusion Proteins - genetics | Head and Neck Neoplasms - genetics | Poly-ADP-Ribose Binding Proteins - immunology | Squamous Cell Carcinoma of Head and Neck - therapy | NFI Transcription Factors - immunology | Care and treatment | Immune response | Patient outcomes | Immunotherapy | Tumor antigens | Head and neck cancer | Genetic aspects | T cells | Identification and classification | Health aspects | Gene fusion | Antigens | Cytotoxicity | Immunosurveillance | Genomes | Lymphocytes T | Ribonucleic acid--RNA | Immunity | Metastases | Gene sequencing | Inhibitors | Immune checkpoint | Immunogenicity | Lymphocytes | Antigen (tumor-associated) | Infiltration | Mutation | Pretreatment | Tumors | Cancer | tumor-antigens | somatic mutations | bcr-abl | induction | blockade | immunotherapy | protein | peptides | cancer | Cancer and Oncology | landscape | Cancer och onkologi
Journal Article
JNCI: Journal of the National Cancer Institute, ISSN 0027-8874, 10/2019
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 440 - 451
Journal Article
Field Crops Research, ISSN 0378-4290, 06/2019, Volume 239, pp. 1 - 9
In Indo-Gangetic Plains, rice-wheat cropping system (RWC) is often practiced on alkaline soils low in organic matter and plant available boron (B). However,... 
Economics | Grain quality | Rice-wheat cropping system | Seed priming | Soil health | AGRONOMY | MANAGEMENT | SEED PRIMING IMPROVES | ESTABLISHMENT | MICROBIAL BIOMASS | EXTRACTION METHOD | ORGANIC-CARBON | NITROGEN | SYSTEMS | RESIDUE | RICE | Soils | Crop yields | Cropping systems | Carbon content | Conservation tillage | Wheat industry | No-tillage | Wheat
Journal Article
Journal Article
Nature, ISSN 0028-0836, 11/2017, Volume 551, Issue 7681, pp. 517 - 520
Checkpoint blockade immunotherapies enable the host immune system to recognize and destroy tumour cells(1). Their clinical activity has been correlated with... 
CELL LUNG-CANCER | CTLA-4 BLOCKADE | MELANOMA | THERAPY | LANDSCAPE | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | SENSITIVITY | RESISTANCE | CLINICAL-RESPONSE | REPERTOIRES | Humans | Lung Neoplasms - pathology | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antigen Presentation | Melanoma - genetics | Immunotherapy | Cell Cycle Checkpoints - genetics | Cell Cycle Checkpoints - immunology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Antigens, Neoplasm - genetics | Antigens, Neoplasm - immunology | Carcinoma, Non-Small-Cell Lung - genetics | Lymphocyte Activation | CTLA-4 Antigen - genetics | Lung Neoplasms - therapy | Melanoma - pathology | CTLA-4 Antigen - immunology | Carcinoma, Non-Small-Cell Lung - immunology | Carcinoma, Non-Small-Cell Lung - therapy | Lung Neoplasms - immunology | Models, Immunological | Melanoma - immunology | Survival Analysis | T-Lymphocytes - immunology | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - antagonists & inhibitors | Melanoma - therapy | Programmed Cell Death 1 Receptor - genetics | Cohort Studies | Evolution, Molecular | Antigens | Care and treatment | Patient outcomes | Models | Health aspects | Tumors | Medical research | Peptides | PD-1 protein | Lung cancer | Melanoma | Cytotoxicity | Lymphocytes T | Patients | Proteins | Cell recognition | CTLA-4 protein | Major histocompatibility complex | Immune checkpoint | Lymphocytes | Evolution | Mutation | Histocompatibility | Cancer | Immune system | Fitness
Journal Article
Science, ISSN 0036-8075, 02/2018, Volume 359, Issue 6375, pp. 582 - 587
CD8(+) T cell-dependent killing of cancer cells requires efficient presentation of tumor antigens by human leukocyte antigen class I (HLA-I) molecules.... 
HIV-1 | METASTATIC MELANOMA | CTLA-4 BLOCKADE | THERAPY | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | MUTATIONAL LANDSCAPE | RESISTANCE | IDENTIFICATION | HISTOCOMPATIBILITY ANTIGENS | MOLECULES | Immunotherapy - methods | Humans | Middle Aged | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Young Adult | Cancer Vaccines - therapeutic use | Antigen Presentation | Melanoma - genetics | Skin Neoplasms - mortality | Adult | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Antigens, Neoplasm - immunology | Treatment Outcome | Histocompatibility Antigens Class I - genetics | Histocompatibility Antigens Class I - chemistry | Cancer Vaccines - immunology | Melanoma - immunology | Skin Neoplasms - genetics | Protein Conformation | Aged | CD8-Positive T-Lymphocytes - immunology | CTLA-4 Antigen - antagonists & inhibitors | Melanoma - therapy | Genetic Carrier Screening | Cohort Studies | Melanoma - mortality | Care and treatment | Histocompatibility antigens | Immunotherapy | HLA histocompatibility antigens | Genotype | Genetic aspects | Health aspects | Cancer | Peptides | CD8 antigen | Genes | Molecular dynamics | Cytotoxicity | Lymphocytes T | Vaccines | Homozygosity | Cancer vaccines | Cell recognition | Genotype & phenotype | Lymphocytes | Genotypes | Immune system | Antigen presentation | Antigens | Melanoma | Epitopes | Patients | Survival | Loci | Heterozygosity | White blood cells | Immune checkpoint | Cell death | Antigen (tumor-associated) | Loss of heterozygosity | Histocompatibility antigen HLA | Mutation | Recognition | Apoptosis
Journal Article
International Journal of Energy Research, ISSN 0363-907X, 01/2019, Volume 43, Issue 1, pp. 491 - 499
Journal Article
by Balachandran, Vinod P and Luksza, Marta and Zhao, Julia N and Makarov, Vladimir and Moral, John Alec and Remark, Romain and Herbst, Brian and Askan, Gokce and Bhanot, Umesh and Senbabaoglu, Yasin and Wells, Daniel K and Cary, Charles Ian Ormsby and Grbovic-Huezo, Olivera and Attiyeh, Marc and Medina, Benjamin and Zhang, Jennifer and Loo, Jennifer and Saglimbeni, Joseph and Abu-Akeel, Mohsen and Zappasodi, Roberta and Riaz, Nadeem and Smoragiewicz, Martin and Kelley, Z. Larkin and Basturk, Olca and Gönen, Mithat and Levine, Arnold J and Allen, Peter J and Fearon, Douglas T and Merad, Miriam and Gnjatic, Sacha and Iacobuzio-Donahue, Christine A and Wolchok, Jedd D and DeMatteo, Ronald P and Chan, Timothy A and Greenbaum, Benjamin D and Merghoub, Taha and Leach, Steven D and Australian Pancreatic Canc Genom and Garvan Institute of Medical Research and Bankstown Hospital and St Vincent’s Hospital and Royal Adelaide Hospital and Royal North Shore Hospital and Envoi Pathology and QIMR Berghofer Medical Research Institute and Prince of Wales Hospital and University of Melbourne, Centre for Cancer Research and University of Queensland, Institute for Molecular Bioscience and Royal Prince Alfred Hospital, Chris O’Brien Lifehouse and Princess Alexandria Hospital and Fremantle Hospital and Liverpool Hospital and Austin Hospital and University of Glasgow and Johns Hopkins Medical Institutes and Flinders Medical Centre and Westmead Hospital and St John of God Healthcare and ARC-Net Centre for Applied Research on Cancer and Australian Pancreatic Cancer Genome Initiative
Nature, ISSN 0028-0836, 11/2017, Volume 551, Issue 7681, pp. S12 - S16
Journal Article